Drug Information Handbook for Psychiatry

Overview

The Drug Information Handbook for Psychiatry is designed for healthcare professionals requiring clear, concise drug information relating to mental health issues. This convenient resource includes monographs for psychotropic, non-psychotropic, and herbal medications.

Benefits

The monographs in this handbook contain multiple fields of information, including adult and pediatric dosing guidelines, FDA-approved and unlabeled uses, medication safety issues, and the following psychiatry-specific fields:

• Mental Health Comment
• Effect on Mental Status
• Effect on Psychiatric Treatment
• Child/Adolescent Considerations

Medications are alphabetically organized by brand and generic name and cross-referenced by page number. Dictionary-like page headings help to expedite a drug search, making this a very user-friendly manual.

The Special Topics/Issues section includes the DSM-IV, general patient assessment guidelines, and rating scales used in patient evaluations. The Appendix includes comparative drug charts, tables, and specific therapy guidelines and recommendations for use in mental health disorders.

Updates to this Edition

• 34 New Drug Monographs
• New Appendix Therapy Guidelines:
• CMS: Long-Term Care Facility Thresholds
• Additional Appendix Updates:
• Stimulant Agents Used for ADHD
• Addiction Treatments
• Depression
• Drugs of Abuse
• Liquid Compatibility of Antidepressants, Antipsychotics, and Mood Stabilizers
• Serotonin Syndrome
• Special Topics Update:
• DSM-IV

Editors

Matthew A. Fuller, PharmD received his Bachelor of Science in Pharmacy from Ohio Northern University and then earned a Doctor of Pharmacy degree from the University of Cincinnati. A residency in hospital pharmacy was completed at Bethesda hospital in Zanesville, Ohio. After completion of his training, Dr Fuller accepted a position at the Veterans Affairs Medical Center in Cleveland, Ohio

Dr Fuller has over 20 years of experience in psychiatric psychopharmacology in a variety of clinical settings including acute care and ambulatory care. Dr Fuller is currently a Clinical Pharmacy Specialist in Psychiatry at the Louis Stokes Cleveland Department of Veterans Affairs Medical Center in Cleveland, Ohio. He is also an Associate Clinical Professor of Psychiatry and Clinical Instructor of Psychology at Case Western Reserve University in Cleveland, Ohio and Adjunct Associate Professor of Clinical Pharmacy at the University of Toledo in Toledo, Ohio. In this position, Dr Fuller is responsible for providing service, education, and research. He is also the Director of an ASHP accredited Psychiatric Pharmacy Practice Residency Program.

Dr Fuller has received several awards including the Upjohn Excellence in Research Award and the OSHP Hospital Pharmacist of the Year Award in 1994. In 1996, he received the CSHP Evelyn Gray Scott Award (Pharmacist of the Year). In 2001, he received the OSHP Pharmacy Practice Research Award.

Dr Fuller is Board Certified by the Board of Pharmaceutical Specialties in both Pharmacotherapy and Psychiatric Pharmacy. He speaks regularly on the topic of psychotropic use and has published articles and abstracts on various issues in psychiatric psychopharmacology. His research interests include the psychopharmacologic treatment of schizophrenia and bipolar disorder.

Dr Fuller is a member of numerous professional organizations, including the College of Psychiatric and Neurologic Pharmacists (CPNP) where he currently is President and the American Society of Health-System Pharmacists (ASHP), where he is designated as a fellow. He completed his term as a member of the Commission on Therapeutics and is a member of the Clinical Specialist Section; Ohio Society of Health-System Pharmacists (OSHP) where he has served as an Educational Affairs Division member and a House of Delegates member; American College of Clinical Pharmacy (ACCP); Ohio College of Clinical Pharmacy where he served as secretary/treasurer; and Cleveland Society of Health-System Pharmacist (CSHP) where he has served as the education chair and treasurer. He is a member of the National Alliance for the Mentally Ill (NAMI) and also serves as a reviewer for pharmacy and psychiatric journals. He is also a member of the psychiatry editorial board for the Annals of Pharmacotherapy.

Martha Sajatovic, MD is Professor of Psychiatry at Case Western Reserve University School of Medicine in Cleveland, Ohio. She is a clinician and researcher with particular interest in health outcomes for individuals with serious mental illness. She also has a strong interest in assessment instruments in psychiatry, and frequently serves as a consultant to pharmaceutical companies for rating scales training, as well as publishing in this area.

Dr Sajatovic received her BS in biology at Ohio State University and completed medical school at the Medical College of Ohio at Toledo. She completed her residency training in psychiatry at University Hospitals of Cleveland where she was Chief Resident in Research. Following completion of her residency, Dr Sajatovic was a Clinical Director of Inpatient Schizophrenia Research at University Hospitals of Cleveland, and later, was the Associate Chief of Psychiatry and Chief of the Mood Disorders Program at the Cleveland Veterans Affairs Medical Center in Cleveland, Ohio. Dr Sajatovic has extensive experience with the management of serious mental illness through her work as a state hospital Chief Clinical Officer (Cleveland Campus Northcoast Behavioral Healthcare), in her own private practice, as an inpatient attending physician in geropsychiatry, and in consulting with agencies providing community services to the seriously mentally ill. In 2003, Dr Sajatovic received an Exemplary Psychiatric Award from the National Alliance for the Mentally Ill (NAMI).

Dr Sajatovic has published a number of original papers on treatment of serious mental illness and treatment outcomes including work with special populations such as the elderly, women with psychosis, and individuals with developmental disorder. She has been a guest lecturer at numerous academic and community settings including speaking to consumer and family advocacy groups for individuals with psychiatric illness. Dr Sajatovic has a long-standing commitment to education including supervision of medical students and residents in psychiatry, lecturing at Case Western Reserve University School of Medicine, psychiatric resident supervision, and seminar teaching for residents in psychiatry.